Web results:
Elsewhere in the so-called "Pfizer documents" being misinterpreted online, the report concluded that the data does not reveal "any novel safety concerns or risks requiring label changes" and...
On Jan. 6, a federal court in the Northern District of Texas ordered the expedited release. As of Jan. 12, the FDA hasn’t indicated it intends to appeal. Scientists Requested Data After FDA Licensing The FDA licensed the Pfizer vaccine on Aug. 23, 2021, just 108 days after Pfizer started producing the records to the agency.
A federal judge in Texas on Thursday ordered the Food and Drug Administration to make public the data it relied on to license Pfizer’s COVID-19 vaccine, imposing a dramatically accelerated...
“Our landmark phase 3 clinical trial (protocol published November 2020) was designed and powered to evaluate efficacy of BNT165b2 to prevent disease caused by SARS-CoV2, including severe disease.
Share. The Food and Drug Administration (FDA) has lost a court battle, to protect the documents they used to approve the company’s COVID-19 vaccine. On Sept. 16, 2021, a complaint was filed in a...
The most recent version of this claim stems from an April 3 Substack article published by investigative reporter Sonia Elijah with the headline, "Was Pfizer's 95% vaccine efficacy fraudulent all...
News Judge scraps 75-year FDA timeline to release Pfizer vaccine safety data, giving agency eight months by Kaelan Deese, Supreme Court Reporter January 07, 2022 10:39 AM The Food and Drug...
The FDA declined to intervene in this case. Some of the documents pertaining to the approval of the Pfizer-BioNTech COVID vaccine that were released on March 1 appear to directly relate to the clinical trials conducted by Ventavia, and thus may shed light on Jackson’s allegations.
The FDA turned over thousands of documents related to its review of Pfizer-BioNTech's COVID-19 vaccine last week, marking the first of several releases mandated by a court in Texas earlier this year.
The figure appears to stem from a Substack article , which makes the claim that Pfizer documents reveal the efficacy rate of its COVID-19 vaccines is 12% - not the 95% reported in clinical trials.